10x Genomics, Inc. Class A Common Stock (TXG) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for TXG. 13F holdings as of 2026-03-31.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| FMR LLC | 17,740,972 | $377M | INCREASED |
| ARK Investment Management LLC | 11,717,317 | $249M | DECREASED |
| BlackRock, Inc. | 10,079,913 | $214M | INCREASED |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6,912,936 | $147M | NEW |
| Quantinno Capital Management LP | 5,411,761 | $115M | INCREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Shehnaaz Suliman (Director) | SELL | 364 | $12K | 2026-06-16 |
| Shehnaaz Suliman (Director) | SELL | 5,359 | $175K | 2026-06-16 |
| Sridhar Kosaraju (Director) | AWARD | 8,829 | 2026-06-04 | |
| Alan Mateo (Director) | AWARD | 8,829 | 2026-06-04 | |
| Kimberly J Popovits (Director) | AWARD | 8,829 | 2026-06-04 |
Full institutional holdings, insider history, and congressional trades for 10x Genomics, Inc. Class A Common Stock on SentiSense.